RABMAB Trademark

Trademark Overview

On Saturday, May 12, 2007, a trademark application was filed for RABMAB with the United States Patent and Trademark Office. The USPTO has given the RABMAB trademark a serial number of 77179558. The federal status of this trademark filing is REGISTERED AND RENEWED as of Saturday, May 25, 2019. This trademark is owned by Epitomics Inc.. The RABMAB trademark is filed in the Chemical Products and Pharmaceutical Products categories with the following description:

Biochemicals, namely, rabbit monoclonal antibodies for in vitro scientific or research use

Diagnostic kits consisting primarily of rabbit monoclonal antibodies, buffers, and reagents for use in disease testing
rabmab

General Information

Serial Number77179558
Word MarkRABMAB
Filing DateSaturday, May 12, 2007
Status800 - REGISTERED AND RENEWED
Status DateSaturday, May 25, 2019
Registration Number3533032
Registration DateTuesday, November 18, 2008
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 2, 2008

Trademark Statements

Goods and ServicesBiochemicals, namely, rabbit monoclonal antibodies for in vitro scientific or research use
Goods and ServicesDiagnostic kits consisting primarily of rabbit monoclonal antibodies, buffers, and reagents for use in disease testing

Classification Information

International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateWednesday, June 11, 2008
Primary Code001
First Use Anywhere DateSaturday, January 1, 2005
First Use In Commerce DateSaturday, January 1, 2005
International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, May 17, 2007
Primary Code005
First Use Anywhere DateSaturday, January 1, 2005
First Use In Commerce DateSaturday, January 1, 2005

Trademark Owner History

Party NameEpitomics Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressWaltham, MA 02453
US
Party NameEpitomics Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBurlingame, CA 94010
US
Party NameEpitomics Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBurlingame, CA 94010
US

Trademark Events

Event DateEvent Description
Thursday, May 17, 2007NEW APPLICATION ENTERED
Friday, August 24, 2007ASSIGNED TO EXAMINER
Tuesday, August 28, 2007NON-FINAL ACTION WRITTEN
Tuesday, August 28, 2007NON-FINAL ACTION E-MAILED
Tuesday, August 28, 2007NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, April 17, 2008ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Thursday, April 17, 2008ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Tuesday, May 13, 2008TEAS PETITION TO REVIVE RECEIVED
Tuesday, May 13, 2008PETITION TO REVIVE-GRANTED
Tuesday, May 13, 2008TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, May 14, 2008ASSIGNED TO LIE
Wednesday, May 14, 2008CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, May 14, 2008TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, June 11, 2008DATA MODIFICATION COMPLETED
Thursday, July 10, 2008FINAL REFUSAL WRITTEN
Thursday, July 10, 2008FINAL REFUSAL E-MAILED
Thursday, July 10, 2008NOTIFICATION OF FINAL REFUSAL EMAILED
Wednesday, July 9, 2008TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, July 11, 2008CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, July 11, 2008TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, July 22, 2008APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, July 29, 2008LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, August 13, 2008NOTICE OF PUBLICATION
Tuesday, September 2, 2008PUBLISHED FOR OPPOSITION
Tuesday, November 18, 2008REGISTERED-PRINCIPAL REGISTER
Friday, March 12, 2010TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, October 12, 2012TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, October 12, 2012ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, September 19, 2013TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, September 19, 2013ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, November 7, 2014TEAS SECTION 8 & 15 RECEIVED
Wednesday, November 26, 2014CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, November 26, 2014REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Wednesday, November 26, 2014NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Friday, January 20, 2017TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, January 20, 2017ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Saturday, November 18, 2017COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Tuesday, April 23, 2019TEAS SECTION 8 & 9 RECEIVED
Saturday, May 25, 2019CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Saturday, May 25, 2019REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Saturday, May 25, 2019REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Saturday, May 25, 2019NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Thursday, September 19, 2019TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, January 6, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, January 6, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, March 18, 2026TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, March 18, 2026APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, March 18, 2026TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, March 18, 2026ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, March 18, 2026TEAS CHANGE OF CORRESPONDENCE RECEIVED

Related Keywords

rabmab monoclonal rabbit antibodies buffers primarily reagents disease consisting testing research